# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1259550 | Functional | Antiviral activity against Vaccinia virus infected in HEL assessed as reduction in virus-induce cytopathicity | Vaccinia virus | 20 | ALA1255569 | organism-based format | Scientific Literature | |
2. | ALA1259551 | Functional | Antiviral activity against Human cytomegalovirus AD169 infected in HEL assessed as reduction in virus-induce cytopathicity | Human betaherpesvirus 5 | 20 | ALA1255569 | organism-based format | Scientific Literature | |
3. | ALA1259552 | Functional | Antiviral activity against Human cytomegalovirus Davis infected in HEL assessed as reduction in virus-induce cytopathicity | Human betaherpesvirus 5 | 20 | ALA1255569 | organism-based format | Scientific Literature | |
4. | ALA1259553 | Functional | Antiviral activity against Human herpesvirus 6 infected in HEL assessed as reduction in virus-induce cytopathicity | Human betaherpesvirus 6 | 20 | ALA1255569 | organism-based format | Scientific Literature | |
5. | ALA1259554 | ADME | Cytotoxicity against HEL assessed as change in cell morphology | Homo sapiens | 22 | ALA1255569 | cell-based format | Scientific Literature | |
6. | ALA1259555 | ADME | Cytotoxicity against human HSB2 cells assessed as change in cell morphology | Homo sapiens | 20 | ALA1255569 | cell-based format | Scientific Literature | |
7. | ALA1259556 | ADME | Cytotoxicity against HEL | Homo sapiens | 22 | ALA1255569 | cell-based format | Scientific Literature | |
8. | ALA1259557 | Functional | Antiviral activity against HSV1 KOS infected in HEL assessed as reduction in virus-induce cytopathicity | Human alphaherpesvirus 1 | 21 | ALA1255569 | organism-based format | Scientific Literature | |
9. | ALA1259558 | Functional | Antiviral activity against acyclovir-resistant HSV1 KOS infected in HEL assessed as reduction in virus-induce cytopathicity | Human alphaherpesvirus 1 | 21 | ALA1255569 | organism-based format | Scientific Literature | |
10. | ALA1259559 | Functional | Antiviral activity against acyclovir-resistant HSV2 strain G infected in HEL assessed as reduction in virus-induce cytopathicity | Human alphaherpesvirus 2 | 21 | ALA1255569 | organism-based format | Scientific Literature | |
11. | ALA1259560 | Functional | Antiviral activity against acyclovir-resistant VZV OKA infected in HEL assessed as reduction in virus-induce cytopathicity | Human betaherpesvirus 5 | 21 | ALA1255569 | organism-based format | Scientific Literature | |
12. | ALA1259561 | Functional | Antiviral activity against acyclovir-resistant VZV 07/1 infected in HEL assessed as reduction in virus-induce cytopathicity | Human betaherpesvirus 5 | 21 | ALA1255569 | organism-based format | Scientific Literature | |
13. | ALA995354 | Functional | Antiviral activity against Camelpox virus CML1 infected in HEL299 cells assessed as inhibition of virus-induced cytopathic effect after 6 days by Giemsa staining | Camelpox virus | 38 | ALA1137668 | organism-based format | Scientific Literature | |
14. | ALA995355 | Functional | Antiviral activity against Camelpox virus CML14 infected in HEL299 cells assessed as inhibition of virus-induced cytopathic effect after 6 days by Giemsa staining | Camelpox virus | 38 | ALA1137668 | organism-based format | Scientific Literature | |
15. | ALA995356 | ADME | Cytotoxicity against HEL299 cells after 4 days by Z1 Coulter counting analysis | Homo sapiens | 38 | ALA1137668 | cell-based format | Scientific Literature | |
16. | ALA995357 | Toxicity | Selectivity index, ratio of CC50 for HEL299 cells to EC50 for Camelpox virus CML1 infected in HEL299 cells | 38 | ALA1137668 | cell-based format | Scientific Literature | ||
17. | ALA995358 | Toxicity | Selectivity index, ratio of CC50 for HEL299 cells to EC50 for Camelpox virus CML14 infected in HEL299 cells | 38 | ALA1137668 | cell-based format | Scientific Literature | ||
18. | ALA995359 | Functional | Antiviral activity against Camelpox virus CML1 infected in human PHK assessed as inhibition of virus-induced cytopathic effect after 6 days by Giemsa staining | Camelpox virus | 38 | ALA1137668 | organism-based format | Scientific Literature | |
19. | ALA995360 | Functional | Antiviral activity against Camelpox virus CML14 infected in human PHK assessed as inhibition of virus-induced cytopathic effect after 6 days by Giemsa staining | Camelpox virus | 38 | ALA1137668 | organism-based format | Scientific Literature | |
20. | ALA995361 | ADME | Cytotoxicity against human PHK after 4 days by Z1 Coulter counting analysis | Homo sapiens | 38 | ALA1137668 | assay format | Scientific Literature |